1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin

BACKGROUND: The combination of piperacillin–tazobactam (PIP-TAZO) and vancomycin is associated with an increased frequency of acute kidney injury (AKI) in patients when compared with either agent alone. Like vancomycin, telavancin is also used for gram-positive infections and has been reported to ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilly, Joseph, Nhan, Ethan, Erb, Rebecca, Whittaker, Cristen A, Trivedi, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809571/
http://dx.doi.org/10.1093/ofid/ofz360.1419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809571/
http://dx.doi.org/10.1093/ofid/ofz360.1419

Ejemplares similares